Cite
Guarnaccia L, Marfia G, Masseroli MM, et al. Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma. Cancers (Basel). 2021;14(1)doi: 10.3390/cancers14010112.
Guarnaccia, L., Marfia, G., Masseroli, M. M., Navone, S. E., Balsamo, M., Caroli, M., Valtorta, S., Moresco, R. M., Campanella, R., Garzia, E., Riboni, L., & Locatelli, M. (2021). Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma. Cancers, 14(1), . https://doi.org/10.3390/cancers14010112
Guarnaccia, Laura, et al. "Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma." Cancers vol. 14,1 (2021). doi: https://doi.org/10.3390/cancers14010112
Guarnaccia L, Marfia G, Masseroli MM, Navone SE, Balsamo M, Caroli M, Valtorta S, Moresco RM, Campanella R, Garzia E, Riboni L, Locatelli M. Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma. Cancers (Basel). 2021 Dec 27;14(1). doi: 10.3390/cancers14010112. PMID: 35008275.
Copy
Download .nbib
